Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03676920 · ClinicalTrials.gov registry record · NA

Feasibility and Utilization of an Application-based Question Prompt List

A NA study of Cancer and Financial Toxicity, sponsored by Barbara Ann Karmanos Cancer Institute.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT03676920 is a NA study of Cancer and Financial Toxicity that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 35 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03676920, a NA study of Cancer and Financial Toxicity, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

This trial studies how well an application-based question prompt list works in improving treatment cost discussion between patients with breast, prostate, lung, or colorectal cancer and their oncologists. An application-based question prompt list, called Discussion of Cost Application (DISCO App), may help to improve how patients and oncologists discuss cancer treatment costs.

Interventions

  • BEHAVIORAL Discussions of Cost App (DISCO App)

Study Locations (1)

Michigan

  • Barbara Ann Karmanos Cancer Institute - Detroit

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2018-08-21
Est. Completion 2019-12-31
Phase NA

What the Registry Record Tells You About NCT03676920

The ClinicalTrials.gov registry entry for NCT03676920 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Barbara Ann Karmanos Cancer Institute, which has 139 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Discussions of Cost App (DISCO App) is the first listed.

NCT03676920 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT03676920 about?

NCT03676920 is a clinical study titled "Feasibility and Utilization of an Application-based Question Prompt List". This trial studies how well an application-based question prompt list works in improving treatment cost discussion between patients with breast, prostate, lung, or colorectal cancer and their oncologists. An application-based question prompt list, called Discussion of Cost Application (DISCO App), m...

What is the current status of trial NCT03676920?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2018-08-21. Estimated completion is 2019-12-31.

What conditions does trial NCT03676920 study?

This clinical trial studies the following conditions: Cancer, Financial Toxicity, Question Prompt List.

What interventions are being tested in trial NCT03676920?

The interventions under investigation include: Discussions of Cost App (DISCO App) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03676920?

This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03676920 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.